<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp>-associated markers are involved in the progression of several <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, but are relatively unstudied in Barrett's <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Our aim was to assess the immunohistochemical expression of <z:mp ids='MP_0005039'>hypoxia</z:mp>-inducible factor (HIF)-1alpha, HIF-2alpha, erythropoietin (Epo), Epo receptor (Epo-R), Glut-1 and vascular endothelial growth factor (VEGF) along with Ki67/MIB-1 in the Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence </plain></SENT>
<SENT sid="2" pm="."><plain>Endoscopic biopsies of <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelium (NSE) (n=20), <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">columnar-lined oesophagus</z:e> (CLO) (n=15), CLO with <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (n=20), <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n=17) and Barrett's type <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n=20) were obtained </plain></SENT>
<SENT sid="3" pm="."><plain>Immunohistochemistry was performed on the paraffin-embedded tissue </plain></SENT>
<SENT sid="4" pm="."><plain>A score was calculated for each marker (range 0-300) by multiplying intensity (none 0, weak 1, moderate 2, strong 3) by percentage of expression (range 0-100) </plain></SENT>
<SENT sid="5" pm="."><plain>Significant increases in the expression of HIF-2alpha (P=0.014), VEGF (P&lt;0.0001), Epo-R (P&lt;0.0001) and Ki67 (P&lt;0.0001) were found as tissue progressed from NSE to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>HIF-2alpha was expressed late in the sequence and was only seen in <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>High HIF-2alpha expression was seen in 12 out of 20 Barrett's type <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>The late expression of HIF-2alpha in the Barrett's <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> sequence and its high expression in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> suggest that it is worth further investigation as a marker of disease progression and therapeutic target </plain></SENT>
</text></document>